Search - tctmd.com

Displaying 81 - 100 of 144

Sort: Relevancy | Date

News Conference News AHA 2015

Varenicline Helps ACS Patients Quit Smoking, But Effect Wanes

November 12, 2015

News Conference News AHA 2015

Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact

November 12, 2015

News Conference News AHA 2015

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Yael L. Maxwell

November 10, 2015

News Conference News AHA 2015

PROMISE Analyses: Coronary CTA May Hold Some Benefits for Patients With Suspected CAD

November 10, 2015

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

November 10, 2015

News Conference News AHA 2015

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

Yael L. Maxwell

November 08, 2015

News Conference News AHA 2015

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

November 08, 2015

News Conference News AHA 2015

Is Watchman Cost-effective? That Depends Where You Look

November 07, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

November 05, 2015

News Conference News AHA 2014

Regional STEMI Care Systems Improve Treatment Times

Yael L. Maxwell

November 18, 2014

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Conference News AHA 2014

AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI

Yael L. Maxwell

November 18, 2014

News Conference News AHA 2014

Role of CTA in Survival Prediction, Resource Utilization Explored

November 17, 2014

News Conference News AHA 2014

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Yael L. Maxwell

November 17, 2014

News Conference News AHA 2014

Novel, Efficient CT-based FFR Outperforms CTA

November 17, 2014

News Conference News AHA 2014

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Yael L. Maxwell

November 17, 2014

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Presentation AHA 2014

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Presenter: Dean J. Kereiakes

November 16, 2014

News Conference News AHA 2014

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

November 16, 2014

News Conference News AHA 2014

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

November 16, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.